Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexible low-dose cetrotide GnRH antagonist regimen in IVF
ChiCTR2000034834Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Shandong Second Medical University
- Start
- Sep 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of cetrorelix in female infertility (2 arms), sponsored by Affiliated Hospital of Shandong Second Medical University. Primary endpoints: β-HCG and Clinical pregnancy rate. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
cetrorelix
03
Conditions
female infertility
Beyond the preview
Go deeper on ChiCTR2000034834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034834.